Key Findings
The global pharmaceutical supply chain management market is anticipated to grow with a CAGR of 8.84% during the forecast period, 2023 to 2032. Some of the top factors bolstering the market’s growth include the increasing application of cloud computing systems in healthcare, the adoption of the GS1 standard system, the mounting pressure to reduce healthcare costs, the surging demand for pharmaceutical products, and the high prevalence of drug counterfeiting.

Market Insights
Pharmaceutical supply chain management (SCM) software facilities the implementation, planning, as well as control of pharmaceutical product flow from the point of origin to consumption. The supply chain in the pharmaceutical industry includes the movement of active ingredients, finished products, raw materials, as well as medical devices from manufacturers to distributors, pharmacies, healthcare facilities, and wholesalers.
The surging incidence of drug counterfeiting in the pharmaceutical industry has generated an increasing need for effective supply chain management solutions. Furthermore, drug counterfeiting is a global problem that poses a substantial threat to public health. Counterfeit drugs may also comprise incorrect doses and harmful substances, resulting in serious health consequences like the failure of treatments or cures, increased risk of prolonged illness, and/or death.
As per the estimations issued by the Pharmaceutical Security Institute, incidents of counterfeit medicine trafficking have heightened significantly, with a 38% rise from 3146 in 2016 to 4344 in 2020 across 137 nations. Besides, in 2020, 2451 different drugs from all therapeutic categories were involved. Hence, the pharmaceutical industry is under tremendous pressure to implement measures that ensure drug safety and authenticity throughout the supply chain, thus propelling the global pharmaceutical supply chain management market growth during the forecasted period.

Regional Insights
The global pharmaceutical supply chain management market growth analysis entails the study of the Asia-Pacific, North America, Europe, and Rest of World. Asia-Pacific is projected to rise with the highest CAGR during the forecast period. The region’s market growth is credited to the increased Internet and mobile device adoption, the sizable pharmaceutical industry in the Asia-Pacific, and the surging adoption of advanced technologies.

Competitive Insights
The competition in the global pharmaceutical supply chain management market is set to be high during the projection period. In addition, key players operating in the global market are McKesson Corporation, Tecsys Inc, Infor, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments